Our objective is to facilitate collaborative endeavors to advance expertise in the dry powder inhalation domain. We invite you to join us in exploring our collective knowledge and progress in this pivotal field.
Ellipta® Blister Device: a Re-assembly Set of Tools for Early In Vitro Comparative Studies of a Complex Pre-Metered Dry Powder Inhaler
Complexitites related to the amorphous content of lactose carriers
Impact of high shear blending on distribution of magnesium stearate on lactose for dry powder inhaled formulations
Understanding impact of fines on flow behaviour of lactose blends with and without magnesium stearate and its impact on filling using membrane filling technology
Impact of Active Pharmaceutical Ingredient Span and the amount of Lactose Fines on Dry Powder Inhaler Formulation Performance
Dry powders for the delivery of biopharmaceuticals to the nose
Smart Specification Setting for Dry Powder Inhalation Carriers
Relvar® Ellipta Generic: Development Of Vilanterol And Fluticasone Furoate In Vitro Bioequivalent Formulations
The data from this contact form will be collected and processed in response to your request. The data will be deleted after your request has been processed. Note: You can revoke your consent at any time in the future by emailing to info@intoinhalation.com. Privacy policies: DFE Pharma / Harro Höfliger / Sterling
I have read and accepted DFE Pharma's privacy policy. I have read and accepted Harro Höfliger's privacy policy. I have read and accepted Sterling's privacy policy.
Δ
Privacy Policy | Imprint